Loading GILD…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("GILD","financials")Full statements spill as a table. For one cell: =jivedata("GILD","Revenue") or =jivedata("GILD","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
GILD • CIK 0000882095
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Operating Income (Loss) | $7,605,000 | $1,662,000 | $10,022,000 | $-2,497,000 |
| InterestExpenseNonoperating | — | $977,000 | $1,024,000 | $998,000 |
| Nonoperating Income (Expense) | $198,000 | $6,000 | $798,000 | $1,539,000 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $6,859,000 | $690,000 | $9,796,000 | $-1,955,000 |
| Income Tax Expense (Benefit) | $1,247,000 | $211,000 | $1,286,000 | $1,285,000 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $5,613,000 | $480,000 | $8,510,000 | $8,510,000 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $-52,000 | $0 | $0 | $0 |
| Net Income (Loss) Attributable to Parent | $5,665,000 | $480,000 | $8,510,000 | $-3,240,000 |
| Weighted Average Number of Shares Outstanding, Basic | 1,248,000,000 | 1,247,000,000 | 1,244,000,000 | 1,241,000,000 |
| Weighted Average Number of Shares Outstanding, Diluted | 1,258,000,000 | 1,255,000,000 | 1,255,000,000 | 1,241,000,000 |
| Revenue from Contract with Customer, Excluding Assessed Tax | $27,116,000 | $28,754,000 | $29,443,000 | $30,457,000 |
| Cost of Goods and Services Sold | $6,498,000 | $6,251,000 | $6,234,000 | $6,216,000 |
| Research and Development Expense (Excluding Acquired in Process Cost) | $5,718,000 | $5,907,000 | $5,799,000 | $6,065,000 |
| Research and Development Asset Acquired Other than Through Business Combination, Written-off | $1,155,000 | $4,663,000 | $1,024,000 | $12,859,000 |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | $50,000 | $4,180,000 | $590,000 | $2,150,000 |
| Selling, General and Administrative Expense | $6,090,000 | $6,091,000 | $5,774,000 | $6,523,000 |
| Costs and Expenses | $19,511,000 | $27,092,000 | $19,421,000 | $32,954,000 |
| Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 10,000,000 | 8,000,000 | 11,000,000 | -1,000,000 |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 4,000,000 | 5,000,000 | 2,000,000 | 11,000,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $6,085,000 | $9,991,000 | $7,564,000 | $3,179,000 |
| Marketable Securities, Current | $1,179,000 | $0 | $68,000 | $0 |
| Property, Plant and Equipment, Net | $5,317,000 | $5,414,000 | $5,606,000 | $5,833,000 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $4,660,000 | $4,420,000 | $4,913,000 | $5,055,000 |
| Marketable Securities, Noncurrent | $1,163,000 | $0 | $2,974,000 | $0 |
| Inventory, Net | $1,787,000 | $1,710,000 | $1,774,000 | $1,953,000 |
| Intangible Assets, Net (Excluding Goodwill) | $26,454,000 | $19,948,000 | $16,978,000 | $14,032,000 |
| Prepaid Expense and Other Assets, Current | $2,374,000 | $3,052,000 | $4,024,000 | $3,759,000 |
| Goodwill | $8,314,000 | $8,314,000 | $8,314,000 | $8,314,000 |
| Assets, Current | $16,085,000 | $19,173,000 | $18,342,000 | $13,945,000 |
| Deferred Income Tax Assets, Net | — | — | $1,964,000 | $2,487,000 |
| Other Assets, Noncurrent | $4,792,000 | $6,146,000 | $4,845,000 | $4,751,000 |
| Assets | $62,125,000 | $58,995,000 | $59,023,000 | $49,362,000 |
| Long-term Debt, Excluding Current Maturities | $23,189,000 | $24,896,000 | $22,129,000 | $23,832,000 |
| Accrued Income Taxes, Noncurrent | $2,039,000 | $830,000 | $896,000 | $943,000 |
| Deferred Income Tax Liabilities, Net | $1,588,000 | $724,000 | $402,000 | $333,000 |
| Other Liabilities, Noncurrent | $1,280,000 | $1,295,000 | $1,165,000 | $1,490,000 |
| Accounts Payable, Current | $550,000 | $833,000 | $715,000 | $674,000 |
| Debt, Current | $1,798,000 | $1,815,000 | $2,807,000 | $2,414,000 |
| Other Liabilities, Current | $5,130,000 | $5,464,000 | $3,953,000 | $3,699,000 |
| Liabilities, Current | $11,280,000 | $12,004,000 | $11,813,000 | $11,020,000 |
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 |
| Common Stock, Value, Issued | $1,000 | $1,000 | $1,000 | $1,000 |
| Additional Paid in Capital | $6,500,000 | $7,700,000 | $8,932,000 | $9,532,000 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $28,000 | $132,000 | $39,000 | $95,000 |
| Retained Earnings (Accumulated Deficit) | $16,304,000 | $11,497,000 | $13,730,000 | $2,200,000 |
| Stockholders' Equity Attributable to Parent | $22,833,000 | $19,330,000 | $22,703,000 | $11,829,000 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $-84,000 | $-84,000 | $-84,000 | $-84,000 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $22,749,000 | $19,246,000 | $22,618,000 | $11,744,000 |
| Preferred Stock, Shares Authorized | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 |
| Preferred Stock, Shares Outstanding | 0 | 0 | 0 | 0 |
| Common Stock, Shares Authorized | 5,600,000,000 | 5,600,000,000 | 5,600,000,000 | 5,600,000,000 |
| Common Stock, Shares, Issued | 1,246,000,000 | 1,246,000,000 | 1,241,000,000 | 1,241,000,000 |
| DebtSecuritiesAvailableForSaleExcludingAccruedInterest | $2,426,000 | $2,426,000 | $3,044,000 | $997,000 |
| Operating Lease, Right-of-Use Asset | $581,000 | $515,000 | $532,000 | $532,000 |
| Operating Lease, Liability, Current | $125,000 | $113,000 | $102,000 | $102,000 |
| Operating Lease, Liability, Noncurrent | $546,000 | $498,000 | $503,000 | $503,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $5,613,000 | $480,000 | $8,510,000 | $8,510,000 |
| Net Cash Provided by (Used in) Operating Activities | $8,006,000 | $10,828,000 | $10,019,000 | $13,552,000 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $57,000 | $-40,000 | $92,000 | $-30,000 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $673,000 | $3,906,000 | $-2,428,000 | $-1,965,000 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $6,085,000 | $9,991,000 | $7,564,000 | $7,266,000 |
| Depreciation | $354,000 | $381,000 | $370,000 | $371,000 |
| Payments to Acquire Debt Securities, Available-for-sale | $1,930,000 | $244,000 | $3,939,000 | $2,203,000 |
| Amortization | $2,339,000 | $2,386,000 | $2,390,000 | $2,389,000 |
| Proceeds from Sale of Debt Securities, Available-for-sale | $510,000 | $2,265,000 | $854,000 | $4,103,000 |
| Share-based Payment Arrangement, Noncash Expense | $766,000 | $835,000 | $894,000 | $909,000 |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | $1,334,000 | $327,000 | $55,000 | $77,000 |
| Deferred Income Tax Expense (Benefit) | $-962,000 | $-1,844,000 | $160,000 | $129,000 |
| Payments to Acquire Businesses, Net of Cash Acquired | $1,152,000 | $4,840,000 | $1,070,000 | $12,094,000 |
| Increase (Decrease) in Equity Securities, FV-NI | $-167,000 | $-274,000 | $451,000 | $1,220,000 |
| Payments to Acquire Other Investments | $442,000 | $492,000 | $133,000 | $131,000 |
| Research and Development Asset Acquired Other than Through Business Combination, Written-off | $1,155,000 | $4,663,000 | $1,024,000 | $12,859,000 |
| Payments to Acquire Property, Plant, and Equipment | $585,000 | $523,000 | $563,000 | $609,000 |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | $50,000 | $4,180,000 | $590,000 | $2,150,000 |
| Payments for (Proceeds from) Other Investing Activities | $1,000 | $-58,000 | $-2,000 | $-18,000 |
| Other Noncash Income (Expense) | $-826,000 | $-353,000 | $-480,000 | $-779,000 |
| Net Cash Provided by (Used in) Investing Activities | $-2,265,000 | $-3,449,000 | $-4,793,000 | $-10,839,000 |
| Proceeds from Debt, Net of Issuance Costs | $1,980,000 | $3,464,000 | $0 | $4,085,000 |
| Proceeds from Issuance of Common Stock | $232,000 | $422,000 | $408,000 | $304,000 |
| Payments for Repurchase of Common Stock | $1,000,000 | $1,150,000 | $1,922,000 | $1,439,000 |
| Repayments of Debt | $2,250,000 | $1,970,000 | $1,788,000 | $2,800,000 |
| Payments of Dividends | $3,809,000 | $3,918,000 | $4,003,000 | $4,068,000 |
| Proceeds from (Payments for) Other Financing Activities | $-279,000 | $-281,000 | $-440,000 | $-729,000 |
| Net Cash Provided by (Used in) Financing Activities | $-5,125,000 | $-3,433,000 | $-7,745,000 | $-4,647,000 |
| Increase (Decrease) in Accounts Receivable | $-157,000 | $-139,000 | $367,000 | $353,000 |
| Increase (Decrease) in Inventories | $842,000 | $426,000 | $1,036,000 | $835,000 |
| Increase (Decrease) in Prepaid Expense and Other Assets | $-39,000 | $259,000 | $311,000 | $412,000 |
| Increase (Decrease) in Accounts Payable | $-347,000 | $290,000 | $-132,000 | $86,000 |
| Increase (Decrease) in Income Taxes | $-1,768,000 | $-732,000 | $-2,108,000 | $-114,000 |
| Increase (Decrease) in Accrued Liabilities | $458,000 | $108,000 | $6,000 | $52,000 |